| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.26B | +0.4% |
| R&D Expense | $152.0M | +5.6% |
| SG&A Expense | $1.86B | -1.2% |
| Operating Income | $2.01B | -8.1% |
| Interest Expense | $183.0M | +18.1% |
| Pre-tax Income | $2.04B | +0.4% |
| Income Tax | $305.0M | -42.8% |
| Net Income | $1.65B | +17.0% |
| EPS (Basic) | $4.10 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.30B | +80.5% |
| Accounts Receivable | $3.43B | -3.1% |
| Inventory | $557.0M | -9.0% |
| Current Assets | $7.67B | +19.8% |
| Total Assets | $11.32B | +11.9% |
| Current Liabilities | $7.75B | +19.6% |
| Long-term Debt | $8.27B | +20.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.56B | -3.9% |
| Investing Cash Flow | -$164.0M | +10.4% |
| Financing Cash Flow | -$309.0M | +77.1% |
| +19.9% |
| EPS (Diluted) | $4.07 | +20.1% |
| Total Liabilities |
| $16.04B |
| +8.1% |
| Stockholders' Equity | -$4.85B | +1.5% |